Navigation Links
MicroAire Surgical Instruments Acquires Endotine® (Formerly Owned by Coapt Systems)
Date:8/19/2010

CHARLOTTESVILLE, Va., Aug. 19 /PRNewswire/ -- MicroAire Surgical Instruments is pleased to announce the acquisition of Endotine® bioabsorbable, multi-point, soft-tissue fixation systems for facial aesthetic surgery. Endotine® is a patented system that allows surgeons to attach soft tissue to bone, or to other soft tissue -- using special tines instead of sutures -- thereby avoiding the tissue-strain associated with sutures.

Although Endotine® devices have the holding power of multiple sutures; the system actually has more in common with hook-and-loop systems, than with traditional needle and thread. This unique system allows surgeons to adjust the degree of lift during surgery. The additional strength from Endotine's® multiple fixation-points reduces tissue stretching and potential suture failure in a variety of facial procedures, including brow lifts, midface lifts, face lifts and neck lifts.

Endotine® is bioabsorbable, which means there are no secondary procedures required for implant removal. Endotine® devices hold tissue securely for three to four months and are then absorbed naturally, typically over a twelve-month period.  With seven years of clinical history, including excellent success rates in peer-reviewed publications, clinical trials showed virtually no issues of inflammation or adverse histologic response.

Customers and distributors of Endotine® devices will see no change in the availability of the products. MicroAire is planning to continue the product, invest in the product and grow the brand.

"Many surgeons already know that this is a fantastic product," said Alan Connor, MicroAire's Vice President of Operations. "We're ensuring that manufacturing and distribution processes remain the same, so that customers and distributors have full access to Endotine® products, as they always have. Same people, same location, same contact information. The only change for now will be the addition of the MicroAire logo, and our commitment to supporting and growing this product line."

MicroAire will continue to use the Coapt name on product packaging and some business documents during the period of product registration and transfer to MicroAire.

MicroAire Surgical Instruments, located in Charlottesville, Virginia, is a leading designer, manufacturer and distributor of surgical products in three key areas:  Orthopaedic Power Instruments, Endoscopic Soft-Tissue Release, and Aesthetic Plastic Surgery. MicroAire is a team, dedicated to enhancing quality of life by providing innovative surgical solutions that improve surgeon and patient outcomes. For more information, visit www.microaire.com.Donald J. Crotteau+1 434 975 8389dj.crotteau@microaire.com
'/>"/>

SOURCE MicroAire Surgical Instruments
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
2. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
3. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
4. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
5. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
6. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
7. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
8. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
9. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
10. Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination
11. New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Calif. , Feb. 4, 2016  Edwards Lifesciences ... patient-focused innovations for structural heart disease and critical care ... accelerated share repurchase (ASR) agreement with Morgan Stanley & ... stock.  This repurchase is part of the Company,s previously ... the Company,s common stock.  --> ...
(Date:2/4/2016)... Feb. 4, 2016 Worldwide Radiology Oncology ... growth as next generation systems provide a way ... for cancer surgery. New systems pinpoint the delivery ... has been such a problem previously, limiting the ... robots take cancer surgery far beyond what has ...
(Date:2/4/2016)... Calif. , Feb. 4, 2016  SciClone ... today announced it has entered into a settlement ... Commission (SEC) fully resolving the SEC,s investigation into ... (FCPA).  Under the terms of the settlement agreement, ... $12.8 million, including disgorgement, pre-judgment interest and a ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe ... signed a joint enrollment and degree completion agreement. The agreement, which begins ... degrees at FHU|Dickson. , The agreement allows students to be jointly admitted ...
(Date:2/5/2016)... ... February 05, 2016 , ... In the fourth ... country gathered at the La Valencia Hotel in San Diego, California to discuss ... named the year’s most outstanding franchise, walking away with the coveted David Wright ...
(Date:2/5/2016)... SARASOTA, Fla., (PRWEB) , ... February 05, 2016 , ... ... appetizing recipes just in time for this weekend’s Big Game. Take the stress out ... ingredients that will keep your guests happy at every stage of the game. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... Stuart Bentkover, MD, FACS is ... to provide the most effective tattoo removal today, Dr. Bentkover is the only doctor ... by Cynosure, the PicoSure has been approved by the Food and Drug Administration (FDA) ...
(Date:2/5/2016)... ... February 05, 2016 , ... Health and wellness is a topic that should ... event they are experiencing an illness. Migraines are a severe form of a headache ... migraines would not wish the pain on their worst enemy, the feeling can last ...
Breaking Medicine News(10 mins):